Story perspectives

TrumpRx Faces Backlash Over Limited Drug Access and Effectiveness

3/19/2026

Summary

Story summary

TrumpRx, the drug pricing platform associated with U.S. President Donald Trump, faces criticism for limited effectiveness amid rising costs.
Millions of uninsured Americans struggle to access prescriptions, and nearly half never see a clinician.
The platform lists only 54 drugs, with many cheaper generics not disclosed.
Geographic restrictions exclude 46 million Americans from using coupons.
Critics say only one drug offers a genuinely lower price than existing options.

1 of 1

Story summary

TrumpRx, the drug pricing platform associated with U.S. President Donald Trump, faces criticism for limited effectiveness amid rising costs.
Millions of uninsured Americans struggle to access prescriptions, and nearly half never see a clinician.
The platform lists only 54 drugs, with many cheaper generics not disclosed.
Geographic restrictions exclude 46 million Americans from using coupons.
Critics say only one drug offers a genuinely lower price than existing options.